(−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis

Chemical composition and acaricidal activity of the essential oils from Vitex agnus-castus L. (Verbenaceae) and selected monoterpenes

(2016) Roberta C.S. Neves et al.   ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS

Cannabinoids and autoimmune diseases: A systematic review

(2016) Valeria Katchan et al.   AUTOIMMUNITY REVIEWS

The Emerging Role of the Cannabinoid Receptor Family in Peripheral and Neuro-immune Interactions

(2016) Orla Haugh et al.   CURRENT DRUG TARGETS

Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise

(2016) Charu Sharma et al.   CURRENT PHARMACEUTICAL DESIGN

Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures

(2016) Cleide Correia de Oliveira et al.   EPILEPSY & BEHAVIOR

The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration

(2016) Magaiver Andrade-Silva et al.   INFLAMMATION RESEARCH

Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta

(2016) Ryan C. McCarthy et al.   Journal of Neuroinflammation

Chemical Composition of Essential Oils from Zanthoxylum bungeanum Maxim. and Their Bioactivities against Lasioderma serricorne

(2016) Wen-Juan Zhang et al.   Journal of Oleo Science

β-caryophyllene, a dietary cannabinoid, complexed with β-cyclodextrin produced anti-hyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn

(2016) Lucindo J. Quintans-Júnior et al.   LIFE SCIENCES

β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes

(2016) Ryosuke Kamikubo et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Canopy level emissions of 2-methyl-3-buten-2-ol, monoterpenes, and sesquiterpenes from an experimental Pinus taeda plantation

(2016) Christopher D. Geron et al.   SCIENCE OF THE TOTAL ENVIRONMENT

Volatile Constituents of the Aerial Parts ofPulicaria sicula(L.)MorisGrowing Wild in Sicily: Chemotaxonomic Volatile Markers of the GenusPulicariaGaertn.

(2015) Antonella Maggio et al.   CHEMISTRY & BIODIVERSITY

Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis

(2015) William G. Notcutt   Neurotherapeutics

Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia

(2014) Kexin Guo et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Constituents of essential oils from the leaves, stem barks and resins ofCanarium parvumLeen., andCanarium tramdenanumDai et Yakovl. (Burseracea) grown in Vietnam

(2014) Tran D. Thang et al.   NATURAL PRODUCT RESEARCH

Neuroprotective Effects of Trans-Caryophyllene Against Kainic Acid Induced Seizure Activity and Oxidative Stress in Mice

(2014) Hao Liu et al.   NEUROCHEMICAL RESEARCH

β-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway

(2014) L.C. Assis et al.   NEUROSCIENCE

�-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway

(2014) Yujie Cheng et al.   PHARMACOLOGY

β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice

(2014) Amine Bahi et al.   PHYSIOLOGY & BEHAVIOR

Immunomodulatory activity of interferon-beta

(2014) Lloyd H. Kasper et al.   Annals of Clinical and Translational Neurology

Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury

(2013) In-Young Choi et al.   AMERICAN JOURNAL OF PATHOLOGY

The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain

(2013) A.-L. Klauke et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta

(2012) Robert A. Bermel et al.   ANNALS OF NEUROLOGY

β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner

(2012) Béla Horváth et al.   FREE RADICAL BIOLOGY AND MEDICINE

β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway

(2011) Allisson Freire Bento et al.   AMERICAN JOURNAL OF PATHOLOGY

Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases

(2011) Ana F. Paszcuk et al.   PLoS One

Cannabis-based medicines in multiple sclerosis – A review of clinical studies

(2010) David J. Rog   IMMUNOBIOLOGY

Cannabinoids and the immune system: An overview

(2010) Radu Tanasescu et al.   IMMUNOBIOLOGY

Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis

(2010) RBC Kavia et al.   Multiple Sclerosis Journal

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Switching first-line disease-modifying therapy after failure: impact on the course of relapsing–remitting multiple sclerosis

(2008) A Gajofatto et al.   Multiple Sclerosis Journal

Beta-caryophyllene is a dietary cannabinoid

(2008) Jürg Gertsch et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA